Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low dose intra-articular tranexamic acid in THA and TKA
NCT02393963Phase 2Completed
- Sponsor
- Orthopaedic Innovation Centre
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in osteoarthritis (OA), sponsored by Orthopaedic Innovation Centre. Started Jul 2015; status: completed.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02393963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02393963.